Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank21
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.12
↓ 146% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
6.79
Historical baseline
PeriodValueYoY Change
2025-3.12-65.1%
2024-1.89-7.9%
2023-1.75+80.1%
2022-8.78+39.5%
2021-14.51+42.5%
2020-25.24-199.5%
201925.37+5.1%
201824.14-52.1%
201750.38+116.7%
201623.25-